UPINITATUG RILSODOTIN
UNII E8US1SQ3B5

Substance Identification & Data

This profile provides standardized clinical and technical data for Upinitatug Rilsodotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) E8US1SQ3B5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2254119-00-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

E8US1SQ3B5

CAS Registry Number

2254119-00-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

UPINITATUG RILSODOTIN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C147577

National Cancer Institute reference terminology for clinical and research data.

INN ID

11318

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Upinitatug Rilsodotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

UPINITATUG RILSODOTIN

Common Names & Synonyms

ANTIBODY-DRUG CONJUGATE ADC XMT-1536

ANTI-NAPI2B ADC XMT-1536

ANTI-NAPI2B/AURISTATIN F-HPA ADC XMT-1536

IMMUNOGLOBULIN G1 (DE-450-LYSINE), ANTI-(HUMAN SODIUM-DEPENDENT PHOSPHATE TRANSPORT PROTEIN 2B) (HUMAN-MUS MUSCULUS MONOCLONAL XMT-1535 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL XMT-1535 .KAPPA.-CHAIN, DIMER, THIOETHER WITH N-(2-CARBOXYETHYL)CARBAMATES 22-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-5,10,20-TRIOXO-13,16-DIOXA-2,6,9,19-TETRAAZADOCOSANOATES DEXTRAN, OXIDIZED, REDUCED, ESTERS WITH N,N-DIMETHYL-L-VALYL-L-VALYL-(3R,4S,5S)-3-METHOXY-5-METHYL-4-(METHYLAMINO)HEPTANOYL-(.ALPHA.R,.BETA.R,2S)-.BETA.-METHOXY-.ALPHA.-METHYL-2-PYRROLIDINEPROPANOYL-N-(3-((2S)-2-((3-(CARBOXYAMINO)-1-OXOPROPYL)AMINO)-1-OXOPROPOXY)PROPYL)-L-PHENYLALANINAMIDE

UPIFITAMAB RILSODOTIN

UPIFITAMAB RILSODOTIN [WHO-DD]

UPINITATUG RILSODOTIN [INN]